In the wake of Dow Chemical Co.’s acquisition of Rohm & Haas, the state Superior Court is considering whether a plaintiff alleging her husband’s brain cancer was caused by a chemical made by Rohm & Haas Co. can subpoena a Dow corporate designee to testify in a deposition.
During oral argument in the state Superior Court Wednesday, defense attorney Nancy J. Gellman of Conrad O’Brien said Dow is subject to Pennsylvania’s general jurisdiction, but the subpoena is directed to a nonparty in the Branham v. Rohm & Haas Co. litigation. “This case is involving a nonparty,” Gellman argued.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]